Ownership

James B. Breitmeyer - Insider Trading & Ownership

Entity: Individual
Summary: The estimated net worth of James B. Breitmeyer is at least $325K dollars as of February 15, 2024. James B. Breitmeyer is the Chief Executive Officer, Director of Oncternal Therapeutics, Inc. and owns shares of Oncternal Therapeutics, Inc. (ONCT) stock worth about $325K.
All Insider Reports: All Insider Reports

Ownership of James B. Breitmeyer

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
ONCT	Oncternal Therapeutics, Inc.	Chief Executive Officer, Director	$325K			Feb 14, 2024
OTIC	OTONOMY, INC.	Director				Jun 21, 2022
ZGNX	ZOGENIX, INC.	Director				Mar 7, 2022

Showing 1 to 3 of 3 entries

Insider Transactions Reported by James B. Breitmeyer:

Showing 0 to 0 of 0 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.